These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35107405)

  • 1. Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application.
    Başaran E; Aykaç K; Yenilmez E; Büyükköroğlu G; Tunali Y; Demirel M
    Pharm Dev Technol; 2022 Feb; 27(2):228-241. PubMed ID: 35107405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
    Yurtdaş-Kırımlıoğlu G
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of HP-β-CD based voriconazole formulations for ocular drug delivery.
    Pahuja P; Kashyap H; Pawar P
    Curr Drug Deliv; 2014; 11(2):223-32. PubMed ID: 24365062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
    Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
    J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes.
    Novac M; Musuc AM; Ozon EA; Sarbu I; Mitu MA; Rusu A; Gheorghe D; Petrescu S; Atkinson I; Lupuliasa D
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.
    Nasongkla N; Wiedmann AF; Bruening A; Beman M; Ray D; Bornmann WG; Boothman DA; Gao J
    Pharm Res; 2003 Oct; 20(10):1626-33. PubMed ID: 14620518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
    Koontz JL; Marcy JE
    J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
    Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
    AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
    Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
    Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
    Liu B; Li W; Nguyen TA; Zhao J
    Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Studies of Piperine Inclusion Complexes in Native and Derivative β-Cyclodextrins.
    Christoforides E; Andreou A; Papaioannou A; Bethanis K
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
    Spamer E; Müller DG; Wessels PL; Venter JP
    Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid.
    Lin HS; Chean CS; Ng YY; Chan SY; Ho PC
    J Clin Pharm Ther; 2000 Aug; 25(4):265-9. PubMed ID: 10971776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and antibacterial activity of plaunotol and plaunoi extracts complexed with hydroxypropyl-β-cyclodextrin.
    Aung WM; Songkro S; Songkharak S; Kaewnopparat N; Wungsintaweekul J
    Saudi Pharm J; 2022 Jun; 30(6):679-692. PubMed ID: 35812138
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.
    de Melo CG; da Costa LAG; Rabello MM; de Albuquerque Wanderley Sales V; Ferreira AS; da Silva PCD; Nishimura RHV; da Silva RMF; de Araújo Rolim L; Neto PJR
    Curr Drug Deliv; 2022; 19(1):86-92. PubMed ID: 34126897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin.
    Gladys G; Claudia G; Marcela L
    Eur J Pharm Sci; 2003 Nov; 20(3):285-93. PubMed ID: 14592694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Wang S; Ding Y; Yao Y
    Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
    Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.